David Windley
Stock Analyst at Jefferies
(4.73)
# 701
Out of 5,051 analysts
808
Total ratings
59%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Reiterated: Buy | $624 → $420 | $433.50 | -3.11% | 70 | Sep 30, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $225 → $340 | $301.86 | +12.64% | 76 | Sep 28, 2026 | |
| OSCR Oscar Health | Reiterated: Hold | $16 → $31 | $34.01 | -8.85% | 8 | Sep 17, 2026 | |
| MEDP Medpace Holdings | Reiterated: Hold | $515 → $560 | $620.05 | -9.68% | 36 | Sep 14, 2026 | |
| CI The Cigna Group | Downgraded: Hold | $330 → $307 | $283.34 | +8.35% | 65 | Aug 3, 2026 | |
| ELV Elevance Health | Reiterated: Buy | $391 → $450 | $422.09 | +6.61% | 78 | Jul 16, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | $135 → $193 | $164.40 | +17.40% | 74 | Jun 25, 2026 | |
| CNC Centene | Reiterated: Hold | $43 → $39 | $67.02 | -41.81% | 88 | Apr 20, 2026 | |
| MOH Molina Healthcare | Reiterated: Hold | $160 → $139 | $204.36 | -31.98% | 60 | Apr 20, 2026 | |
| UNH UnitedHealth Group | Reiterated: Buy | $340 → $373 | $378.52 | -1.46% | 73 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $18 | $19.24 | -9.04% | 15 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $365 → $295 | $367.60 | -19.75% | 42 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $255 | $262.21 | -2.75% | 59 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $20 | $18.15 | +7.44% | 14 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $9.5 | $21.00 | n/a | 3 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.75 → $3 | $0.3532 | n/a | 2 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $263 | $218.98 | n/a | 2 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $335 | $295.85 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $15 | $9.24 | n/a | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $177 → $190 | $44.56 | n/a | 3 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $200 → $248 | $5.92 | n/a | 5 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8.5 | $5.07 | n/a | 10 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $4.25 | n/a | 4 | Aug 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $0.3905 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $274.78 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $0.66 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $176.54 | n/a | 1 | Nov 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $40.26 | n/a | 1 | Aug 27, 2009 |
Humana
Sep 30, 2026
Reiterated: Buy
Price Target: $624 → $420
Current: $433.50
Upside: -3.11%
Charles River Laboratories International
Sep 28, 2026
Reiterated: Buy
Price Target: $225 → $340
Current: $301.86
Upside: +12.64%
Oscar Health
Sep 17, 2026
Reiterated: Hold
Price Target: $16 → $31
Current: $34.01
Upside: -8.85%
Medpace Holdings
Sep 14, 2026
Reiterated: Hold
Price Target: $515 → $560
Current: $620.05
Upside: -9.68%
The Cigna Group
Aug 3, 2026
Downgraded: Hold
Price Target: $330 → $307
Current: $283.34
Upside: +8.35%
Elevance Health
Jul 16, 2026
Reiterated: Buy
Price Target: $391 → $450
Current: $422.09
Upside: +6.61%
ICON Public Limited Company
Jun 25, 2026
Reiterated: Buy
Price Target: $135 → $193
Current: $164.40
Upside: +17.40%
Centene
Apr 20, 2026
Reiterated: Hold
Price Target: $43 → $39
Current: $67.02
Upside: -41.81%
Molina Healthcare
Apr 20, 2026
Reiterated: Hold
Price Target: $160 → $139
Current: $204.36
Upside: -31.98%
UnitedHealth Group
Apr 20, 2026
Reiterated: Buy
Price Target: $340 → $373
Current: $378.52
Upside: -1.46%
Feb 10, 2026
Reiterated: Hold
Price Target: $21 → $18
Current: $19.24
Upside: -9.04%
Feb 10, 2026
Reiterated: Buy
Price Target: $365 → $295
Current: $367.60
Upside: -19.75%
Feb 6, 2026
Reiterated: Buy
Price Target: $225 → $255
Current: $262.21
Upside: -2.75%
Nov 20, 2025
Reiterated: Buy
Price Target: $16 → $20
Current: $18.15
Upside: +7.44%
Sep 8, 2025
Reiterated: Hold
Price Target: $21 → $9.5
Current: $21.00
Upside: n/a
Aug 25, 2025
Reiterated: Hold
Price Target: $2.75 → $3
Current: $0.3532
Upside: n/a
Jun 4, 2025
Reiterated: Hold
Price Target: $263
Current: $218.98
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: $280 → $335
Current: $295.85
Upside: n/a
Apr 21, 2025
Reiterated: Hold
Price Target: $16 → $15
Current: $9.24
Upside: n/a
Apr 26, 2021
Reiterated: Buy
Price Target: $177 → $190
Current: $44.56
Upside: n/a
Feb 25, 2021
Reiterated: Hold
Price Target: $200 → $248
Current: $5.92
Upside: n/a
Aug 4, 2020
Rated: Hold
Price Target: $7 → $8.5
Current: $5.07
Upside: n/a
Aug 21, 2017
Reiterated: Buy
Price Target: $28
Current: $4.25
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $36
Current: $0.3905
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $129
Current: $274.78
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $9.5
Current: $0.66
Upside: n/a
Nov 28, 2016
Reiterated: Hold
Price Target: $68
Current: $176.54
Upside: n/a
Aug 27, 2009
Downgraded: Hold
Price Target: $12
Current: $40.26
Upside: n/a